» Articles » PMID: 37551971

The Choline-binding Proteins PspA, PspC, and LytA of and Their Interaction with Human Endothelial and Red Blood Cells

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

is a Gram-positive opportunistic pathogen that can colonize the upper respiratory tract. It is a leading cause of a wide range of infectious diseases, including community-acquired pneumonia and meningitis. Pneumococcal infections cause 1-2 million deaths per year, most of which occur in developing countries. Here, we focused on three choline-binding proteins (CBPs), i.e., PspC, PspA, and LytA. These pneumococcal proteins have different surface-exposed regions but share related choline-binding anchors. These surface-exposed pneumococcal proteins are in direct contact with host cells and have diverse functions. We explored the role of the three CBPs on adhesion and pathogenicity in a human host by performing relevant imaging and functional analyses, such as electron microscopy, confocal laser scanning microscopy, and functional quantitative assays, targeting biofilm formation and the hemolytic capacity of . biofilm formation assays and electron microscopy experiments were used to examine the ability of knockout mutant strains lacking the lytA, pspC, or pspA genes to adhere to surfaces. We found that LytA plays an important role in robust synthesis of the biofilm matrix. PspA and PspC appeared crucial for the hemolytic effects of on human red blood cells. Furthermore, all knockout mutants caused less damage to endothelial cells than wild-type bacteria, highlighting the significance of each CPB for the overall pathogenicity of . Hence, in addition to their structural function within the cell wall of , each of these three surface-exposed CBPs controls or mediates multiple steps during bacterial pathogenesis.

Citing Articles

Investigation of choline-binding protein of CbpD in the pathogenesis of type 2.

Zhu L, Li M, Yu G, Zhan D, Zeng W, Fu N Front Vet Sci. 2024; 11:1486347.

PMID: 39691375 PMC: 11649669. DOI: 10.3389/fvets.2024.1486347.


Streptococcus pneumoniae epidemiology, pathogenesis and control.

Narciso A, Dookie R, Nannapaneni P, Normark S, Henriques-Normark B Nat Rev Microbiol. 2024; .

PMID: 39506137 DOI: 10.1038/s41579-024-01116-z.


The role of pneumococcal extracellular vesicles on the pathophysiology of the kidney disease hemolytic uremic syndrome.

Battista M, Hoffmann B, Bachelot Y, Zimmermann L, Teuber L, Jost A mSphere. 2023; 8(4):e0014223.

PMID: 37358300 PMC: 10449520. DOI: 10.1128/msphere.00142-23.

References
1.
Geno K, Gilbert G, Song J, Skovsted I, Klugman K, Jones C . Pneumococcal Capsules and Their Types: Past, Present, and Future. Clin Microbiol Rev. 2015; 28(3):871-99. PMC: 4475641. DOI: 10.1128/CMR.00024-15. View

2.
Hayhurst E, Kailas L, Hobbs J, Foster S . Cell wall peptidoglycan architecture in Bacillus subtilis. Proc Natl Acad Sci U S A. 2008; 105(38):14603-8. PMC: 2567149. DOI: 10.1073/pnas.0804138105. View

3.
Privratsky J, Newman P . PECAM-1: regulator of endothelial junctional integrity. Cell Tissue Res. 2014; 355(3):607-19. PMC: 3975704. DOI: 10.1007/s00441-013-1779-3. View

4.
Grangeasse C . Rewiring the Pneumococcal Cell Cycle with Serine/Threonine- and Tyrosine-kinases. Trends Microbiol. 2016; 24(9):713-724. DOI: 10.1016/j.tim.2016.04.004. View

5.
Heinen S, Hartmann A, Lauer N, Wiehl U, Dahse H, Schirmer S . Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation. Blood. 2009; 114(12):2439-47. DOI: 10.1182/blood-2009-02-205641. View